Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II SOL regimen first-line study in unresectable advanced colorectal cancer
ChiCTR-TNRC-10000838Phase 2Recruiting
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Mar 2010
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur, folinic acid and oxaliplatin in colorectal cancer (CRC), sponsored by Sun Yat-sen University Cancer Center. Primary endpoints: Objective response rate and Progression-free survival. Started Mar 2010; status: recruiting.
02
Drugs
tegafurfolinic acidoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR-TNRC-10000838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-10000838.